Molecular-Biological Methods of Quality Control of Biological Active Substances Produced by Recombinant DNA Technology
Biotechnological products manufactured by recombinant DNA technology are widely used nowadays. According to the national and international requirements the amount of residual host cell DNA in such products should not exceed 10 ng per dose. However, for products intended for frequent or long-term...
Saved in:
Main Authors: | E. D. Mytsa, N. V. Chertova, E. V. Elbert, A. S. Sukhno, R. A. Volkova, V. A. Merkulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-06-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Diagnostics of Histoplasmosis
by: A. V. Lipnitsky, et al.
Published: (2019-10-01) -
Molecular genetic methods in biomedical research. Part III: human gene diagnostics in clinical practice
by: A. N. Volkov, et al.
Published: (2021-09-01) -
Molecular genetic techniques in current biomedical research. Part I: Theoretical basis of PCR -diagnostics
by: A. N. Volkov, et al.
Published: (2020-12-01) -
Effect of Antibiotic Therapy on the Sensitivity of Etiological Diagnostic Methods in Patients with Infective Endocarditis after Surgery
by: E. O. Kotova, et al.
Published: (2023-03-01) -
On assessing the viral safety of individual units of the substance "Human plasma for fractionation" by nucleic acid amplification
by: E. V. Elbert, et al.
Published: (2023-10-01)